Against a backdrop of a tough funding environment, nearly half (48%) of biotechs are using partnerships with Big Pharmas as a financing method, according to a survey commissioned by CRO Icon. Venture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback